ロード中...
Physiologically Based Pharmacokinetic/Pharmacodynamic Modeling to Predict the Impact of CYP2C9 Genetic Polymorphisms, Co-Medication and Formulation on the Pharmacokinetics and Pharmacodynamics of Flurbiprofen
Physiologically based pharmacokinetic/pharmacodynamic (PBPK/PD) models can serve as a powerful framework for predicting the influence as well as the interaction of formulation, genetic polymorphism and co-medication on the pharmacokinetics and pharmacodynamics of drug substances. In this study, flur...
保存先:
| 出版年: | Pharmaceutics |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI
2020
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7693160/ https://ncbi.nlm.nih.gov/pubmed/33147873 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/pharmaceutics12111049 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|